Loading...
XSTO
SERT
Market cap17mUSD
Dec 05, Last price  
0.64SEK
1D
-0.16%
1Q
21.99%
Jan 2017
-87.47%
IPO
-74.19%
Name

Serstech AB

Chart & Performance

D1W1MN
XSTO:SERT chart
P/E
P/S
3.10
EPS
Div Yield, %
Shrs. gr., 5y
22.54%
Rev. gr., 5y
22.76%
Revenues
52m
-16.93%
911,497491,1181,131,8902,700,97817,496,22116,805,68110,588,10118,742,15320,488,00018,651,00017,112,00062,913,00052,262,000
Net income
-9m
L
-839,375-3,543,243-8,402,447-8,116,858-6,417,469-2,547,047-12,330,561-15,877,170-6,730,000-10,252,000-29,566,000715,000-9,131,000
CFO
562k
-92.64%
-1,866,43300005,893,000-11,823,000-10,586,0003,558,000-628,000-13,158,0007,631,000562,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Serstech AB provides chemical identification instruments worldwide. It offers the Serstech 100 Indicator, a handheld, small, and light Raman spectrometer for measuring chemicals, such as explosives, narcotics, toxic industrial chemicals, pharmaceuticals, and chemical warfare agents; and ChemDash, a central management software for Serstech devices. The company also provides Serstech Arx and Serstech Arx+ revolutionizing instruments for quick and precise identification of chemical substances; and Serstech's SERS kit that allows for quick identification of low concentrations and narcotics samples. It offers its solutions for explosive, CBRN and hazmat, narcotics, and pharma applications. Serstech AB was incorporated in 2006 and is headquartered in Lund, Sweden.
IPO date
Aug 29, 2013
Employees
20
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT